8.20
1.11%
0.09
Finanzdaten der Aura Biosciences Inc-Aktie (AURA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Research and Development |
15.92%
17.05
|
20.28 | 15.43 | 15.12 | 14.40 |
Operating Income/Loss |
9.97%
-22.31
|
-24.78 | -20.49 | -20.28 | -19.44 |
Nonoperating Income/Loss |
4.88%
2.653
|
2.789 | 1.976 | 1.977 | 1.978 |
Income/Loss From Continuing Operations Before Tax |
10.61%
-19.66
|
-21.99 | -18.51 | -18.30 | -17.47 |
Income Tax Expense/Benefit |
0.046
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
10.96%
-19.71
|
-22.13 | -18.51 | -18.30 | -17.47 |
Net Income/Loss
|
10.96%
-19.71
|
-22.13 | -18.51 | -18.30 | -17.47 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,849%
49.45
|
1.6769 | 38.19 | 37.86 | 37.78 |
Diluted Average Shares |
2,849%
49.45
|
1.6769 | 38.19 | 37.86 | 37.78 |
Basic Earnings Per Share |
20.00%
-0.40
|
-0.50 | -0.48 | -0.48 | -0.46 |
Diluted Earnings Per Share |
20.00%
-0.40
|
-0.50 | -0.48 | -0.48 | -0.46 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):